Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00050908 · ClinicalTrials.gov registry record
Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 75
- Enrollment target
NCT00050908: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00050908 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00050908 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This is a substudy of ACTG A5142. The purpose of this substudy is to evaluate blood vessel function in HIV-infected patients taking anti-HIV drugs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Est. Completion | 2007-05 |
What the finished NCT00050908 record still lists
NCT00050908 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00050908 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00050908 about?
NCT00050908 is a clinical study titled "Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs". This is a substudy of ACTG A5142. The purpose of this substudy is to evaluate blood vessel function in HIV-infected patients taking anti-HIV drugs.
What is the current status of trial NCT00050908?
This trial is currently completed. The enrollment target is 75 participants. Estimated completion is 2007-05.
Who is sponsoring clinical trial NCT00050908?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors